OPKO Health, Inc. Disposal Group, Including Discontinued Operation, Revenue
OPKO Health, Inc. (OPK) reported Disposal Group, Including Discontinued Operation, Revenue of $0 for the 12-month period ending 2012-12-31, per its 10-K filed 2014-03-03.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue · last filed 2014-03-03
- OPKO Health, Inc. disposal group, including discontinued operation, revenue for the quarter ending 2011-12-31 was $112.00K.
- OPKO Health, Inc. disposal group, including discontinued operation, revenue for the quarter ending 2011-09-30 was $730.00K.
- OPKO Health, Inc. disposal group, including discontinued operation, revenue for the quarter ending 2011-06-30 was $1.71M.
- OPKO Health, Inc. disposal group, including discontinued operation, revenue for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- OPKO Health, Inc. disposal group, including discontinued operation, revenue for fiscal 2011 was $4.25M, a 49.27% decline from fiscal 2010.
- OPKO Health, Inc. disposal group, including discontinued operation, revenue for fiscal 2010 was $8.39M.
| Period end | Disposal Group, Including Discontinued Operation, Revenue 3 month | Disposal Group, Including Discontinued Operation, Revenue 6 month | Disposal Group, Including Discontinued Operation, Revenue 9 month | Disposal Group, Including Discontinued Operation, Revenue 12 month |
|---|---|---|---|---|
| 2012-12-31 | $0.00 10-K · filed 2014-03-03 | |||
| 2011-12-31 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $842.00K derived: sum of 2 quarters · filed 2014-03-03 | $2.56M derived: sum of 3 quarters · filed 2014-03-03 | $4.25M 10-K · filed 2014-03-03 |
| 2011-09-30 | $730.00K 10-Q · filed 2012-11-09 | $2.44M derived: sum of 2 quarters · filed 2012-11-09 | $4.14M 10-Q · filed 2012-11-09 | |
| 2011-06-30 | $1.71M 10-Q · filed 2012-08-09 | $3.41M 10-Q · filed 2012-08-09 | ||
| 2010-12-31 | $8.39M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |